As of 2026-03-31, the Relative Valuation of West Pharmaceutical Services Inc (WST) is 220.13 USD. This relative valuation is based on P/E multiples. With the latest stock price at 245.14 USD, the upside of West Pharmaceutical Services Inc based on Relative Valuation is -10.2%.
The range of the Relative Valuation is 199.98 - 236.22 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.0x - 32.9x | 31.7x |
| Forward P/E multiples | 23.8x - 28.2x | 26.6x |
| Fair Price | 199.98 - 236.22 | 220.13 |
| Upside | -18.4% - -3.6% | -10.2% |
| Date | P/E |
| 2026-03-30 | 35.79 |
| 2026-03-27 | 35.53 |
| 2026-03-26 | 36.23 |
| 2026-03-25 | 36.06 |
| 2026-03-24 | 35.81 |
| 2026-03-23 | 35.24 |
| 2026-03-20 | 34.61 |
| 2026-03-19 | 35.09 |
| 2026-03-18 | 34.89 |
| 2026-03-17 | 34.96 |
| 2026-03-16 | 35.09 |
| 2026-03-13 | 34.38 |
| 2026-03-12 | 33.74 |
| 2026-03-11 | 34.78 |
| 2026-03-10 | 34.14 |
| 2026-03-09 | 36.22 |
| 2026-03-06 | 35.90 |
| 2026-03-05 | 35.68 |
| 2026-03-04 | 36.33 |
| 2026-03-03 | 36.70 |
| 2026-03-02 | 36.68 |
| 2026-02-27 | 37.13 |
| 2026-02-26 | 36.36 |
| 2026-02-25 | 36.19 |
| 2026-02-24 | 35.83 |
| 2026-02-23 | 35.66 |
| 2026-02-20 | 35.20 |
| 2026-02-19 | 35.60 |
| 2026-02-18 | 36.25 |
| 2026-02-17 | 35.51 |
| 2026-02-13 | 36.57 |
| 2026-02-12 | 35.57 |
| 2026-02-11 | 35.94 |
| 2026-02-10 | 35.56 |
| 2026-02-09 | 36.34 |
| 2026-02-06 | 36.35 |
| 2026-02-05 | 33.82 |
| 2026-02-04 | 34.61 |
| 2026-02-03 | 33.72 |
| 2026-02-02 | 34.67 |
| 2026-01-30 | 33.74 |
| 2026-01-29 | 33.97 |
| 2026-01-28 | 34.44 |
| 2026-01-27 | 35.12 |
| 2026-01-26 | 35.24 |
| 2026-01-23 | 34.55 |
| 2026-01-22 | 36.18 |
| 2026-01-21 | 37.25 |
| 2026-01-20 | 36.57 |
| 2026-01-16 | 37.93 |